These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2575661)

  • 1. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
    Hommel E
    J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
    Rossing K; Christensen PK; Jensen BR; Parving HH
    Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotective action of angiotensin-converting enzyme inhibition in diabetes mellitus.
    Parving HH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S19-24. PubMed ID: 1382160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
    Baba T; Ishizaki T
    Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.
    Jerums G; Allen TJ; Gilbert RE; Hammond J; Cooper ME; Campbell DJ; Raffaele J
    J Diabetes Complications; 1995; 9(4):308-14. PubMed ID: 8573754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
    Jacobsen P; Andersen S; Jensen BR; Parving HH
    J Am Soc Nephrol; 2003 Apr; 14(4):992-9. PubMed ID: 12660333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Svendsen PA
    Lancet; 1983 May; 1(8335):1175-9. PubMed ID: 6133986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH; Rossing P; Hommel E; Smidt UM
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy.
    Pedersen MM; Hansen KW; Schmitz A; Sørensen K; Christensen CK; Mogensen CE
    Kidney Int; 1992 Apr; 41(4):883-90. PubMed ID: 1355149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy in patients with diabetic nephropathy.
    Mehler PS; Schrier RW
    Kidney Blood Press Res; 1997; 20(2):74-81. PubMed ID: 9293422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
    Jacobsen P; Rossing K; Parving HH
    Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.